Bayer AG (ADR) (BAYRY.PK)
$76.60
-3.44 (-4.30%)
| CAPS Rating |
|
|---|---|
| Open | $75.15 |
| Previous Close | $80.04 |
| Daily Range | $74.97 - $76.95 |
| 52-Week Range | $42.65 - $80.24 |
| Market Cap | $65.74B |
| P/E Ratio | 441.67 |
| Dividend (Yield) | 1.37 (1.70%) |
| Volume | 15,581 |
| Average Daily Volume | 63,000 |
BAYRY.PK
VS S&P 500 (SPY)
How do you think BAYRY.PK will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BAYRY.PK Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
Related News and Articles
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool
- 52-Week Highs! What's Going On? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- The Side Effect of Developing Obesity Drugs – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- Are These Dividends Too Good to Be True? – The Motley Fool
- This Baby Is a Nice Addition – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
- 4-Star Stocks Poised to Pop: Merck – The Motley Fool
- Pfizer Dodges a Bullet – The Motley Fool
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- Why You Can't Afford to Miss These Stocks – The Motley Fool
- The Government Won't Be There for You – The Motley Fool
RSS Headlines
Fool UK
